Take That, Double Chins: FDA Panel Unanimously Backs Kythera’s ATX-101
An FDA advisory panel voted unanimously to approve Kythera’s ATX-101 for the reduction of moderate-to-severe submental fat in adults.
An FDA advisory panel voted unanimously to approve Kythera’s ATX-101 for the reduction of moderate-to-severe submental fat in adults.